RecallDepth
Class II Terminated

Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

This recall has been terminated (originally issued May 25, 2022).

Company
Pfizer Inc.
Recall Initiated
April 22, 2022
Posted
May 25, 2022
Recall Number
D-0873-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,304 bottles
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls